XML 17 R7.htm IDEA: XBRL DOCUMENT v3.24.1.u1
Consolidated Statements of Stockholders' Equity - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Non-Controlling Interest
Beginning balance (in shares) at Dec. 31, 2022   289,014,487        
Beginning balance at Dec. 31, 2022 $ 573,454 $ 2,890 $ 1,030,466 $ (89,740) $ (370,866) $ 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 45,490       45,490  
Other comprehensive (loss) income 366     366    
Dividends declared (14,522)       (14,522)  
Shares issued in connection with deferred compensation plan (in shares)   1,052,738        
Shares issued in connection with deferred compensation plan (13,626) $ 11 (11)   (13,626)  
Deferred compensation plan elective participant deferrals 1,533   1,533      
Shares issued in connection with executive bonus plan, net (in shares)   79,804        
Shares issued in connection with executive bonus plan 3,059 $ 1 5,483   (2,425)  
Shares issued in connection with employee stock purchase plan, net (in shares)   153,381        
Shares issued in connection with employee stock purchase plan, net 4,335 $ 1 4,556   (222)  
Stock option exercises, net (in shares)   928,300        
Stock option exercises, net 2,501 $ 9 4,193   (1,701)  
Stock-based compensation expense 14,625   14,625      
Shares related to restricted stock, net (in shares)   272,561        
Shares related to restricted stock, net (3,025) $ 3 (3)   (3,025)  
Ending balance (in shares) at Mar. 31, 2023   291,501,271        
Ending balance at Mar. 31, 2023 614,190 $ 2,915 1,060,842 (89,374) (360,897) 704
Beginning balance (in shares) at Dec. 31, 2023   296,265,837        
Beginning balance at Dec. 31, 2023 883,982 $ 2,963 1,127,234 (84,987) (161,932) 704
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 70,310       70,310  
Other comprehensive (loss) income (7,632)     (7,632)    
Dividends declared (17,871)       (17,871)  
Shares issued in connection with deferred compensation plan (in shares)   537,745        
Shares issued in connection with deferred compensation plan 0 $ 5 (5)      
Deferred compensation plan elective participant deferrals 58   58      
Shares issued in connection with executive bonus plan, net (in shares)   65,939        
Shares issued in connection with executive bonus plan 3,351 $ 1 3,350      
Shares issued in connection with employee stock purchase plan, net (in shares)   122,020        
Shares issued in connection with employee stock purchase plan, net 5,385 $ 1 5,559   (175)  
Stock option exercises, net (in shares)   844,283        
Stock option exercises, net 1,812 $ 8 3,999   (2,195)  
Stock-based compensation expense 13,947   13,947      
Shares related to restricted stock, net (in shares)   481,456        
Shares related to restricted stock, net (5,729) $ 5 (5)   (5,729)  
Repurchases of Class B common stock under approved program (in shares)   (302,598)        
Repurchases of Class B Common Stock under approved program (15,006) $ (3)     (15,003)  
Ending balance (in shares) at Mar. 31, 2024   298,014,682        
Ending balance at Mar. 31, 2024 $ 932,607 $ 2,980 $ 1,154,137 $ (92,619) $ (132,595) $ 704